Announcements Trials

Browse Landscape

Phase

Status

Terminated 3 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Fatigue 1 Depression 1 Brain Neoplasms 1 Anxiety Disorders 1

Interventions

Magnetic Resonance Spectroscopy 23 Radiosurgery 21 Temozolomide 14 Bevacizumab 11 pembrolizumab 10 Specimen Handling 9 Nivolumab 8 Radiotherapy 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Watchful Waiting 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Methylphenidate × Clear all

NCT06905587 2026-04-23

EMBRAIN

Odense University Hospital

Phase 3 Recruiting

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡